PIGP

Chr 21AR

phosphatidylinositol glycan anchor biosynthesis class P

Also known as: DCRC, DCRC-S, DEE55, DSCR5, DSRC, EIEE55, PIG-P

This gene encodes an enzyme involved in the first step of glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells that serves to anchor proteins to the cell surface. The encoded protein is a component of the GPI-N-acetylglucosaminyltransferase complex that catalyzes the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). This gene is located in the Down Syndrome critical region on chromosome 21 and is a candidate for the pathogenesis of Down syndrome. This gene has multiple pseudogenes and is a member of the phosphatidylinositol glycan anchor biosynthesis gene family. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Feb 2016]

Primary Disease Associations & Inheritance

Developmental and epileptic encephalopathy 55MIM #617599
AR
0
Active trials
68
Pathogenic / LP
239
ClinVar variants
3
Pubs (1 yr)
-0.6
Missense Z
1.37
LOEUF
Clinical SummaryPIGP
🧬
Gene-Disease Validity (ClinGen)
developmental and epileptic encephalopathy, 55 · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
68 Pathogenic / Likely Pathogenic· 93 VUS of 239 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.37LOEUF
pLI 0.002
Z-score 0.88
OE 0.66 (0.341.37)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.56Z-score
OE missense 1.18 (0.991.40)
92 obs / 78.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.66 (0.341.37)
00.351.4
Missense OE1.18 (0.991.40)
00.61.4
Synonymous OE1.24
01.21.6
LoF obs/exp: 5 / 7.6Missense obs/exp: 92 / 78.1Syn Z: -1.03
GOFDN
DN
0.7230th %ile
GOF
0.72top 25%
LOF
0.2873th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

239 submitted variants in ClinVar

Classification Summary

Pathogenic65
Likely Pathogenic3
VUS93
Likely Benign67
Benign9
Conflicting2
65
Pathogenic
3
Likely Pathogenic
93
VUS
67
Likely Benign
9
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
65
0
65
Likely Pathogenic
1
1
1
0
3
VUS
6
68
19
0
93
Likely Benign
0
0
29
38
67
Benign
0
5
3
1
9
Conflicting
2
Total77411739239

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

PIGP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

PIGP-related multiple congenital anomalies-hypotonia-seizures syndrome

moderate
ARUndeterminedAbsent Gene Product, Altered Gene Product Structure
Dev. Disorders
G2P ↗
start lostmissense variantframeshift variant NMD triggering

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence